Novel Corona Virus (SARS-CoV-2) Ag Rapid Test
Principle: Rapid chromatographic immunoassay/Lateral-flow assay
Automation: No
Approvals: CE-IVD
Suitability: Detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.
Capital equipment required: No
Description:
Key Points:
Rapid chromatographic immunoassay (lateral-flow) for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.(Catalog Number: SC30107W)
Key Points:
- Fast: results within 15 minutes
- Easy to use: 3 steps to finish the test
- Complete: all necessary components provided
- Safe: swab in protective packaging to avoid biohazard
- Quality Control: ensures the result is reliable
- Clinical Sensitivity: 96.7%
- Clinical Specificity: 97.9%
- Limit of Detection: 1.0 x 102 TCID50/mL
- Sample type: nasal/nasopharyngeal swabs
- Storage temperature: 4 - 30oC
- Transportation temperature: -20 - 45oC
- Package: 20 or 50 Tests per box
Please note : Any products described on this page are
for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.
Areas:
Tags:
Company contact details:
BioPerfectus view full details
China Medical City
Taizhou
China
Website: Visit Website
Tel: +86 021-64193032
BioPerfectus view full details
China Medical City
Taizhou
China
Website: Visit Website
Tel: +86 021-64193032